OLFM4, olfactomedin-4, is reported to be significantly increased in head and neck squamous cell carcinoma (75% tested), suggesting a potential biomarker in this type of cancer [33]. This evidence concerns the gene OLFM4 and head and neck squamous cell carcinoma.